Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 529  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


REVIEW ARTICLE
Year : 2020  |  Volume : 12  |  Issue : 3  |  Page : 223-233

The early mortality rate of people infected with coronavirus (COVID-2019) in Wuhan, China: Review of three retrospective studies


1 Pharmacy Practice, College of Pharmacy, Gulf Medical University, Ajman, UAE
2 College of Pharmacy, Gulf Medical University, Ajman, UAE
3 Clinical Pharmacist, Omdurman Islamic University, Omdurman, Sudan
4 Department of Epidemiology and Population Health, Khalifa University, Abu Dhabi, UAE
5 Ambulatory Healthcare Services, Academic Affairs, Abu Dhabi Health Services (SEHA), Abu Dhabi, UAE
6 Department of Clinical Pharmacy, College of Pharmacy, Taif University, Riyadh, Saudi Arabia
7 Department of Pharmacist, College of Pharmacy, Khartoum University, Khartoum, Sudan
8 Clinical pharmacy, College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia
9 Dentist, MySmile Dental Clinic, Dubai, UAE
10 Assistant Professor, Program of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain, UAE

Correspondence Address:
Prof. Asim Ahmed Elnour
Pharmacy Practice, College of Pharmacy, Gulf Medical University, Ajman.
UAE
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jpbs.JPBS_282_20

Rights and Permissions

Background: The infection with coronavirus and non-survivor cases have been escalated since the first inception between January and March 2020. Therefore, reviewing the collated clinical characteristics of non-survivors might assist in current preventive efforts, triaging, and management of survivors. The aim of this review was to summarize the clinical characteristics of non-survivor cases due to the infection caused by a novel coronavirus and to identify the relevant data that might put the new cases at increased mortality. Materials and Methods: We have identified three published articles on novel coronavirus reported during December 01, 2019, to March 15, 2020, which have described the mortality rate in Wuhan, Hubei, China. Results: The mean duration of studies (i.e., the three retrospective studies with 278 cases) was 24.7 days, and the duration of onset to dyspnea was variable between 8 and 5 days. The main reported complications were acute respiratory distress, pneumonia, acute kidney injury, and acute cardiac disease. The overall major comorbidity reported was cardiovascular diseases at 23.7% (66 of 278). The reported overall mortality rate was 8.3% (23 of 278), with the highest mortality rate of 15.0% (6 of 41) reported in Jin Yintan Hospital at Wuhan city. Conclusions: The clinical characteristics of the non-survivors from the novel coronavirus included adult males, aged older than 50 years, having comorbidities of cardiovascular disease, respiratory distress syndrome, acute kidney injury, and diabetes with higher admission to the intensive care unit. The mortality rate was high in two of the reported studies (15.0% and 11.0%), which was decreased in the later-dated study to 3.4%.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed901    
    Printed33    
    Emailed0    
    PDF Downloaded34    
    Comments [Add]    

Recommend this journal